Mackay is to leave GSK at the end of 2023 and become an independent non-executive director of Schroders next year.

Corley will join the board in September and succeed Michael Dobson as chair after the company’s AGM in April 2022.

Advisory group calls on companies to “embed positive social impact in business as usual”, which would increase the number of “investable” companies for social impact investors to target.